Skip to main content

MoneyWorks4Me

Divis Laboratories board to consider unaudited financial result

28 Oct 2013 Evaluate

Divis Laboratories has informed that a meeting of the Board of Directors of the Company will be held on November 08, 2013, to consider and approve, the un-audited financial results for the half year and quarter ended September 30, 2013 (Q2).

The above information is a part of company’s filings submitted to BSE

Peers
Company Name CMP
Sun Pharma. Inds. 1885.10
Dr. Reddys Labs. 1390.50
Cipla 1414.95
Lupin 2010.00
Zydus Lifesciences 1195.05
View more..